Interest of the association azacitidine-lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype. [electronic resource]
Producer: 20120604Description: 822-4 p. digitalISSN:- 1476-5551
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.